Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 4, 2021, after the close
10-Q filed Nov 4, 2021, 35 days after period end · 0000320017-21-000108
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$6.93M | -$5.33M | -$4.90M | -$3.55M |
| EPS Diluted | -$1.74 | -$0.29 | -$0.47 | -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
